tetano
Editor, Senior Moderator
Virus Evol
. 2024 Sep 2;10(1):veae071.
doi: 10.1093/ve/veae071. eCollection 2024. SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification
Bethany L Dearlove[SUP] 1 2 [/SUP], Anthony C Fries[SUP] 3 [/SUP], Nusrat J Epsi[SUP] 2 4 [/SUP], Stephanie A Richard[SUP] 2 4 [/SUP], Anuradha Ganesan[SUP] 2 4 5 [/SUP], Nikhil Huprikar[SUP] 5 [/SUP], David A Lindholm[SUP] 6 7 [/SUP], Katrin Mende[SUP] 2 4 7 [/SUP], Rhonda E Colombo[SUP] 2 4 6 8 [/SUP], Christopher Colombo[SUP] 8 [/SUP], Hongjun Bai[SUP] 1 2 [/SUP], Derek T Larson[SUP] 9 [/SUP], Evan C Ewers[SUP] 9 [/SUP], Tahaniyat Lalani[SUP] 2 4 10 [/SUP], Alfred G Smith[SUP] 10 [/SUP], Catherine M Berjohn[SUP] 4 6 11 [/SUP], Ryan C Maves[SUP] 12 [/SUP], Milissa U Jones[SUP] 13 [/SUP], David Saunders[SUP] 6 [/SUP], Carlos J Maldonado[SUP] 14 [/SUP], Rupal M Mody[SUP] 15 [/SUP], Samantha E Bazan[SUP] 16 [/SUP], David R Tribble[SUP] 4 [/SUP], Timothy Burgess[SUP] 4 [/SUP], Mark P Simons[SUP] 4 [/SUP], Brian K Agan[SUP] 2 4 [/SUP], Simon D Pollett[SUP] 2 4 [/SUP], Morgane Rolland[SUP] 1 2 [/SUP]
Affiliations
Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections have been important for all circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant periods, but the contribution of vaccine-specific SARS-CoV-2 viral diversification to vaccine failure remains unclear. This study analyzed 595 SARS-CoV-2 sequences collected from the Military Health System beneficiaries between December 2020 and April 2022 to investigate the impact of vaccination on viral diversity. By comparing sequences based on the vaccination status of the participant, we found limited evidence indicating that vaccination was associated with increased viral diversity in the SARS-CoV-2 spike, and we show little to no evidence of a substantial sieve effect within major variants; rather, we show that rapid variant replacement constrained intragenotype COVID-19 vaccine strain immune escape. These data suggest that, during past and perhaps future periods of rapid SARS-CoV-2 variant replacement, vaccine-mediated effects were subsumed with other drivers of viral diversity due to the massive scale of infections and vaccinations that occurred in a short time frame. However, our results also highlight some limitations of using sieve analysis methods outside of placebo-controlled clinical trials.
Keywords: SARS-CoV-2; sieve analysis; vaccine breakthrough; variants.
. 2024 Sep 2;10(1):veae071.
doi: 10.1093/ve/veae071. eCollection 2024. SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification
Bethany L Dearlove[SUP] 1 2 [/SUP], Anthony C Fries[SUP] 3 [/SUP], Nusrat J Epsi[SUP] 2 4 [/SUP], Stephanie A Richard[SUP] 2 4 [/SUP], Anuradha Ganesan[SUP] 2 4 5 [/SUP], Nikhil Huprikar[SUP] 5 [/SUP], David A Lindholm[SUP] 6 7 [/SUP], Katrin Mende[SUP] 2 4 7 [/SUP], Rhonda E Colombo[SUP] 2 4 6 8 [/SUP], Christopher Colombo[SUP] 8 [/SUP], Hongjun Bai[SUP] 1 2 [/SUP], Derek T Larson[SUP] 9 [/SUP], Evan C Ewers[SUP] 9 [/SUP], Tahaniyat Lalani[SUP] 2 4 10 [/SUP], Alfred G Smith[SUP] 10 [/SUP], Catherine M Berjohn[SUP] 4 6 11 [/SUP], Ryan C Maves[SUP] 12 [/SUP], Milissa U Jones[SUP] 13 [/SUP], David Saunders[SUP] 6 [/SUP], Carlos J Maldonado[SUP] 14 [/SUP], Rupal M Mody[SUP] 15 [/SUP], Samantha E Bazan[SUP] 16 [/SUP], David R Tribble[SUP] 4 [/SUP], Timothy Burgess[SUP] 4 [/SUP], Mark P Simons[SUP] 4 [/SUP], Brian K Agan[SUP] 2 4 [/SUP], Simon D Pollett[SUP] 2 4 [/SUP], Morgane Rolland[SUP] 1 2 [/SUP]
Affiliations
- PMID: 39386074
- PMCID: PMC11463026
- DOI: 10.1093/ve/veae071
Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections have been important for all circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant periods, but the contribution of vaccine-specific SARS-CoV-2 viral diversification to vaccine failure remains unclear. This study analyzed 595 SARS-CoV-2 sequences collected from the Military Health System beneficiaries between December 2020 and April 2022 to investigate the impact of vaccination on viral diversity. By comparing sequences based on the vaccination status of the participant, we found limited evidence indicating that vaccination was associated with increased viral diversity in the SARS-CoV-2 spike, and we show little to no evidence of a substantial sieve effect within major variants; rather, we show that rapid variant replacement constrained intragenotype COVID-19 vaccine strain immune escape. These data suggest that, during past and perhaps future periods of rapid SARS-CoV-2 variant replacement, vaccine-mediated effects were subsumed with other drivers of viral diversity due to the massive scale of infections and vaccinations that occurred in a short time frame. However, our results also highlight some limitations of using sieve analysis methods outside of placebo-controlled clinical trials.
Keywords: SARS-CoV-2; sieve analysis; vaccine breakthrough; variants.